| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.01 |